Isomerase Therapeutics Limited
Private Limited Company · Cambridge
ActiveUnited KingdomIncorporated 2012Private Limited Company
Financial snapshot
Full financialsPeriod ended 2025-12-31GBPunknown accounts
Net assets
£2.72mLatest reporting periodCash at bank
£1.83mLatest reporting periodTurnover
Not availableNot in extracted metricsEmployees
38Latest reporting periodBalance sheet
GBP · unknownInsufficient comparable history
At least two periods with a known, matching scope are required.
Inspect coverageCompany record
- Company number
- 08335008
- Incorporated
- 2012-12-18
- Legal form
- Private Limited Company
- Registered office
- 1FIRST FLOOR, NEWNHAM BUILDING, CAMBRIDGE, CB10 1XL
- SIC codes
- 23112
People & control
View all4Current role holders0Control records without an end date0Outstanding security records
OfficerOther current roles
Robert Boothdirector
10Barrie Wilkinsondirector
1Steven Mossdirector
3Matthew Gregorydirector
3No control records without an end date are available. Ownership is not established from this alone.
Activity timeline
- Accounts period ended
GBP · 163 source facts
- Accounts period ended
GBP · 156 source facts
- Simon Eric Aspland resigned
director
- Simon Eric Aspland appointed
director
- Robert Booth appointed
director
- Barrie Wilkinson appointed
director
Connected companies
Open networkBioengine Limited75–100% shares · 75–100% votes
12459879Biotide Limited75–100% shares · 75–100% votes
12461717Spiral Bio Limited75–100% shares
10668530Capital & security
Public records and extracted accounts. Missing figures are unknown, not zero. Research matches are not necessarily direct awards.